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Summary: A questionnaire was administered to a cohort of 130 HIV seropositive women 
attending the Department of Genitourinary Medicine, St James’s Hospital, Dublin, in order 
to establish their current contraceptive practices. Forty (42%) of the sexually active women 
did not use reliable contraception; 55 (57%) used a method reliable in fertility control only, 
and 21 (22%) used a method reliable in terms of both partner and congenital transmission. 
The intravenous drug users were less likely to use reliable contraception, 9 (39%), in 
comparison to the heterosexual group 14 (70%), P<0.05. The heterosexual group were 
more likely to use condoms consistently, 7 (35%) in comparison to one (4%) of intravenous 
drug users, P<0.02. Nineteen children, 3 borne to heterosexual mothers and 16 borne to 
intravenous drug-using mothers were HIV seropositive after 18 months. 
Keywords: HIV, female, contraception 
INTRODUCTION 
Current predictions suggest that the heterosexual and 
congenital modes of HIV transmission will be of 
prime importance in the future1’2. Up until 
December 1991, 1188 people had tested HIV 
positive in Ireland; 39.5% of all cases are IV drug-
related and 9% are heterosexual. This compares to 
1986 where there were no heterosexual cases. The 
number of children HTV seropositive at birth for the 
same period is 783. 
 HIV seropositive women will need to be 
targeted in terms of prevention of spread of the 
virus. On this basis, all newly diagnosed carriers of 
HTV attending the Department of Genitourinary 
Medicine are instructed by experienced counsellors 
on safe sexual practices. 
Goedert4 has outlined strategies based on abstention 
as a primary aim, but where this is not acceptable 
numerous laboratory and epidemiological studies 
have confirmed the reliability of the condom, when 
used properly, in preventing virus transmission5’9. 
 This study assesses the contraceptive practices 
of a cohort of Irish HIV seropositive women who 
have been fully counselled on safe sexual practices. 
PATIENTS AND METHODS 
All HIV seropositive women attending the 
Department of Genitourinary Medicine, St James’s 
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Hospital, Dublin, between July 1991 and December 
1991 were included in the study. One hundred and 
thirty of a cohort of 150 women completed a 
questionnaire designed to enquire about current 
marital status, parity, number of HIV seropositive 
children, sexual activity, intravenous drug-using 
activity, HIV status of regular partner and 
contraceptive usage. 
Age, mode of HIV acquisition and duration 
of known HIV seropositive status were established 
from the records. The patients were classified 
according to the Centers for Disease Control, 
(CDC), Atlanta, 1987, revision of case definition for 
AIDS10. 
There was a total of 130 women whose 
median age was 27 years (mean 25, range 20-36). 
The presumed method of HIV acquisition was 
intravenous drug use in 109 (84%) of the 130 
women and heterosexual contact in 21 (16%). The 
range in duration of ‘known HIV seropositive status 
was between 2 months and 7 years, the mean being 
3 years. 
There were 77 CDC 11 patients, 31 CDC 111 
patients and 22 CDC IV patients. 
RESULTS 
Marital status and children 
Marital status frequently changed since first being 
diagnosed HIV seropositive, but at the time of 
questioning, 90 women were single, 19 were 
married, 16 were separated, 4 were widowed and 
one woman was divorced. 
 
Table 1. Children of HIV seropositive mothers 
Risk category for 
HIV acquisition 
No. 
mothers 
No. 
children 
No. HIV + after 
18 months 
Hetero 15 33 3
Ex-IVDU 51 121 12
Current IVDU 27 52 4
Total 93 206 19
 There were 37 nulliparous women; 93 women 
were parous or multiparous, the highest parity being 
7+2. Of the parous women, 16 had had spontaneous 
abortions and 2 had had terminations of pregnancy. 
Three women were currently pregnant and a total of 
19 children were HIV seropositive 18 months after 
birth (Table 1). 
Sexual activity and partner status 
Thirty-five (27%) of the women were not currently 
sexually active by virtue of ill health, no current 
partner, partner imprisonment or self imposed 
abstinence. Of the 95 women who were sexually 
active, 84 (65%) stated that they had one regular 
partner only of whom 35 (38%) had not been tested 
or denied testing and 17 (20%) had been tested and 
were currently HIV negative. The number of sexual 
partners of the other 11 (8%) women ranged from 2 
to greater than 10 with 6 women admitting to 
prostitution. 
Contraceptive usage 
Of the non-sexually. active women, one used a 
combined oral contraceptive for regulation of the 
menses and one had an intrauterine contraceptive 
device (IUCD) in situ. Of the currently sexually 
active women 55 (57%) used a reliable method of 
contraception in terms of fertility control and 21 
(22%) used a method reliable in terms of both 
heterosexual and vertical transmission (Table 2). 
 A hysterectomy was indicated for one woman 
who had cervical malignancy and the husband of one 
patient was confirmed to be sterile. Six patients were 
using condoms in addition to another method of 
contraception. 
Table 2. Contraceptive usage in sexually active HIV seropositive women 
Contraceptive 
Risk group 
Hetero 
Ex-IVDU Current 
IVDU 
Condom 7 13 1
Oral contraceptive pill 5 11 2
Depoprovera 2 6 2
Intrauterine 
contraceptive device 
1 1 3
Tubal ligation 0 4 1
Hysterectomy 0 1 0
Male sterilization 1 0 0
None 6 20 14
Two methods 2 4 0
Total 20 52 23
Table 3. Risk category for HIV acquisition 
 Hetero Ex-IVDU Current 
IVDU 
P value 
No. contraception *6 (30%) 20 (38%) *14 (61%) P<0.05 
Fertility control only 14 (70%) 32 (61%) 9 (39%) 
Condoms *7 (35%) 13 (25%) *1 (4%) P<0.02 
*Heterosexual versus current IVDU, Chi-squared 4.1, P=0.0429, 
P<0.05 
+ Heterosexual versus current IVDU, Fisher exact test, P=0.0165, 
P<0.02 
 There was a statistically significant difference 
between the contraceptive practices of the 
heterosexual group and the current intravenous drug 
users. The intravenous drug users were likely to use 
reliable contraception, 9 (39%) in comparison to the 
heterosexual group 14 (70%) P<0.05. 
 The heterosexual group were more likely to 
use condoms consistently, 7 (35%) in comparison to 
one (4%) of intravenous drug users, P < 0.02. There 
was no statistical difference between the 
contraceptive practices of the ex-intravenous drug-
users when compared to the heterosexual group 
(Table 3). 
DISCUSSION 
This group of HTV seropositive women 
demonstrate a poor uptake of effective contraceptive 
measures in limiting the vertical and heterosexual 
transmission of the human immunodeficiency virus. 
With no cure for HTV infection, to date, the main 
strategy is health promotion and disease prevention 
by effective education means. 
Various strategies have been proposed in general 
terms11-12. Goedert is more specific in advocating 
the elimination rather than the reduction of risky 
behaviour4. The uptake of this advice in Irish 
seropositive women was poor despite expert 
counselling. The overall use of contraception was 
low and the consistent use of condoms was also 
disappointing (22%), in view of numerous 
laboratory and epidemiological studies which 
confirm their reliability in preventing virus 
transmission5-9. 
It is worthwhile noting that Irish legislation may 
contribute to limiting contraceptive availability. 
Condoms can only be sold by registered pharmacists 
or Family Planning Clinics and only to individuals 
of 17 years or over. The oral contraceptive pill was 
only first licensed for contraceptive purposes in 
1980. Efforts are made to overcome these 
difficulties by providing condoms free of charge in 
the Department of Genitourinary Medicine. 
Drug users are not necessarily representative of all 
HIV infected women. They tend to change to safe 
drug-using practices but not to safe sexual 
behaviour13. This is borne out by the poor uptake of 
safe contraception in the study group, the majority 
of whom have been IV drug users, but most 
particularly in the current IV drug-using group. It 
must not be forgotten that the source of infection 
can still be heterosexual and the social 
problems of this group should not overshadow the 
‘need to avoid disease spread by the sexual route. 
 The number of pregnancies and children borne 
to these women is a major concern. Some studies 
suggest that the decision to have a child was 
unaffected by factors relating to HIV infection 
including the woman’s health and a previously 
infected child14. This may be more of a problem in 
the Irish context, where there is a high national birth 
rate (14.9 per 1000 population in 1991) and where 
social welfare payments and housing provision are 
dictated by the number of children in a family. 
 It can be concluded from this analysis that our 
current patient education methods are insufficient in 
reliably controlling the heterosexual and congenital 
transmission of HIV in this patient group. 
References 
1 Department of Health/Welsh Office. Short-term 
prediction of HIV infection and AIDS. Report 
of a working group. London: HMSO, 1988 
2 Chin J. Current and future dimensions of the 
HIV/AIDS pandemic in women and children. 
Lancet 1990;336:221-4 
3 Department of Health, Republic of Ireland. 
Statistics from 1188 HIV seropositive cases up 
to December 1991 
4 Geodert J. Sounding Board. What is safe sex? 
N Engl J Med 1987;316:1339-41 
5 Valdiserri RO, Arena VC, Proctor D, Bonati 
FA. The relationship between women’s 
attitudes about condoms and 
their use; implications for condom promotion 
programmes. Am J Public Health 1989;79:499-
501 
6 Conant M, Hardy D, Sernatinger J, Spicer D, 
Levy JA. Condoms prevent transmission of 
AIDS associated retrovirus (letter). JAMA 
1986; 255:1706 
7 Ngugi EN, Plummer FA, Simonsen JN, et al. 
Prevention of transmission in Africa. 
Effectiveness of condom promotion and health 
education among prostitutes. Lancet 
1988;ii:887-90 
8 Van de Perre P, Jacobs D, Sprecher-
Goldberger S. An efficient barrier against 
sexual transmission of AIDS related viruses. 
AIDS 1987;1(1):30-3 
9 Hooykaas C, Van der Pligt J, Van Doornum 
GJ, Van der Linden MM, Coutinha RA. 
Heterosexual risk for HIV. Differences 
between private and commercial partners in 
sexual behaviour and condom use. AIDS 
1989;3(8):525-32 
10 Centers for Disease Control, Atlanta, Georgia. 
Revision of case definition for AIDS, for 
surveillance purposes. MMWR 1987;36:No 15 
11 Friedland GH, Klein RS. Transmission of 
human immunodeficiency virus. N Engl J Med 
1987;317:1125-35 
12 Hearst N, Hulley SB. Preventing the 
heterosexual spread of AIDS. JAMA 
1988;259:2428-32 
13 Hart G. Presentation at IVth International 
Conference on AIDS, Stockholm 1988 
14 Selwyn PA, Carter RJ, Schoenbaum EE, et al. 
Knowledge of HIV antibody status and 
decisions to continue or terminate pregnancy 
among intravenous drug users. JAMA 1989; 
261:3567-71 
(Accepted 25 October 1992) 
